0001562180-19-004053.txt : 20190724
0001562180-19-004053.hdr.sgml : 20190724
20190724163832
ACCESSION NUMBER: 0001562180-19-004053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190722
FILED AS OF DATE: 20190724
DATE AS OF CHANGE: 20190724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: West Thomas A.
CENTRAL INDEX KEY: 0001620705
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 19971395
MAIL ADDRESS:
STREET 1: 250 CAMPUS DRIVE
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-07-22
false
0001271214
Intersect ENT, Inc.
XENT
0001620705
West Thomas A.
C/O INTERSECT ENT, INC.
1555 ADAMS DRIVE
MENLO PARK
CA
94025
true
true
false
false
President and CEO
Common Stock
2019-07-22
4
A
false
138455.00
0.00
A
138455.00
D
Stock Options (Right to buy)
20.44
2019-07-22
4
A
false
97960.00
0.00
A
2029-07-21
Common Stock
97960.00
97960.00
D
Stock Options (Right to buy)
20.44
2019-07-22
4
A
false
427147.00
0.00
A
2029-07-21
Common Stock
427147.00
427147.00
D
Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date.
Restricted Stock Units.
The vesting commencement date of the option is July 22, 2019. 1/8th of the shares subject to the option shall vest on January 22, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.
Shares subject to this option shall vest on the third anniversary from the date of grant provided that certain 30-day trailing average stock price (the "Average Closing Price") targets are achieved at any time during the three year period following the date of grant. 33 1/3%, 66 2/3% or 100% of the shares will vest if the Average Closing Price equals or exceeds specific stock price targets.
/s/ David A. Lehman, Attorney-in-Fact for Thomas A West
2019-07-24
EX-24
2
thomaswest_poa2019.txt
THOMAS WEST JULY 2019 POA
POWER OF ATTORNEY
Know all by these present, that the undersigned hereby
constitutes and appoints each of JERYL L. HILLEMAN and DAVID A. LEHMAN,
signing individually, the undersigned's true and lawful attorneys-in
fact and agents to:
(1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer, director or beneficial
owner of more than 10% of a registered class of securities of
Intersect ENT, Inc. (the "Company"), (a) Forms 3, 4 and 5
(including any amendments thereto) in accordance with Section
16(a) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act") and the rules thereunder and a (b) Form ID,
Uniform Application for Access Codes to File on EDGAR;
(2) do and perform any and all acts for and on behalf of
the undersigned that may be necessary or desirable to execute
such Forms 3, 4 or 5 or Form ID (including any amendments
thereto) and timely file such forms with the United States
Securities and Exchange Commission and any stock exchange or
similar authority; and
(3) take any other action of any nature whatsoever in
connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit, in the best interest of, or
legally required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's
discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing
whatsoever requisite, necessary or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do
or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that
the foregoing attorneys-in-fact, in serving in such capacity at the
request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect
until the earliest to occur of (a) the undersigned is no longer
required to file Forms 3, 4 and 5 with respect to the undersigned's
holdings of and transactions in securities issued by the Company, (b)
revocation by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact or (c) as to any attorney-in-fact
individually, until such attorney-in-fact is no longer employed by
the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of July 23, 2019.
/s/ Thomas A. West
______________
Thomas A. West